NasdaqCM - Delayed Quote USD

Enlivex Therapeutics Ltd. (ENLV)

1.3400 -0.0400 (-2.90%)
At close: June 7 at 4:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Operating Expense
25,151.0000
25,151.0000
25,797.0000
19,288.0000
9,785.0000
--
Operating Income
-25,151.0000
-25,151.0000
-25,797.0000
-19,288.0000
-9,785.0000
--
Net Non Operating Interest Income Expense
1,551.0000
1,551.0000
821.0000
-208.0000
219.0000
--
Other Income Expense
-5,468.0000
-5,468.0000
-6,084.0000
5,028.0000
-2,258.0000
--
Pretax Income
-29,068.0000
-29,068.0000
-31,060.0000
-14,468.0000
-11,824.0000
--
Net Income Common Stockholders
-29,068.0000
-29,068.0000
-31,060.0000
-14,468.0000
-11,824.0000
--
Diluted NI Available to Com Stockholders
-29,068.0000
-29,068.0000
-31,060.0000
-14,468.0000
-11,824.0000
--
Basic EPS
-1.56
--
-1.69
-0.81
-0.90
-1.11
Diluted EPS
-1.56
--
-1.69
-0.81
-0.90
-1.11
Basic Average Shares
18,574.4840
--
18,394.8860
17,859.7130
13,169.2080
8,649.4860
Diluted Average Shares
18,574.4840
--
18,394.8860
17,859.7130
13,169.2080
8,649.4860
Total Operating Income as Reported
-29,395.0000
-29,395.0000
-25,797.0000
-19,288.0000
-9,785.0000
--
Total Expenses
25,151.0000
25,151.0000
25,797.0000
19,288.0000
9,785.0000
--
Net Income from Continuing & Discontinued Operation
-29,068.0000
-29,068.0000
-31,060.0000
-14,468.0000
-11,824.0000
--
Normalized Income
-23,600.0000
-23,600.0000
-24,976.0000
-19,496.0000
-9,566.0000
--
Interest Income
1,565.0000
1,565.0000
835.0000
120.0000
225.0000
--
Net Interest Income
1,551.0000
1,551.0000
821.0000
-208.0000
219.0000
--
EBIT
-25,151.0000
-25,151.0000
-25,797.0000
-19,288.0000
-9,785.0000
--
EBITDA
-24,316.0000
-24,316.0000
-25,020.0000
-18,742.0000
-9,499.0000
--
Reconciled Depreciation
835.0000
835.0000
777.0000
546.0000
286.0000
--
Net Income from Continuing Operation Net Minority Interest
-29,068.0000
-29,068.0000
-31,060.0000
-14,468.0000
-11,824.0000
--
Total Unusual Items Excluding Goodwill
-5,468.0000
-5,468.0000
-6,084.0000
5,028.0000
-2,258.0000
--
Total Unusual Items
-5,468.0000
-5,468.0000
-6,084.0000
5,028.0000
-2,258.0000
--
Normalized EBITDA
-18,848.0000
-18,848.0000
-18,936.0000
-23,770.0000
-7,241.0000
--
12/31/2019 - 7/31/2014

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

BLRX BioLineRx Ltd.
0.6576
-5.59%
 
PLUR Pluri Inc.
5.80
+3.02%
 
EVGN Evogene Ltd.
0.6949
+2.19%
 
PPBT Purple Biotech Ltd
0.5720
-7.17%
 
CGEN Compugen Ltd.
2.1100
-1.86%
 
CANF Can-Fite BioPharma Ltd.
2.4700
-3.39%
 
MDWD MediWound Ltd.
17.04
+0.71%
 
XTLB XTL Biopharmaceuticals Ltd.
2.2700
-5.42%
 
LCTX Lineage Cell Therapeutics, Inc.
0.9700
-1.02%
 
ORMP Oramed Pharmaceuticals Inc.
2.1000
-3.67%